Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
23-26 March, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

17 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/17/3189117/0/en/Ashvattha-Therapeutics-to-Showcase-Topline-Phase-2-Data-and-Recent-FDA-Alignment-at-Upcoming-Investor-and-Ophthalmology-Meetings.html

14 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/14/3166111/0/en/Ashvattha-Therapeutics-Appoints-Ophthalmology-Veteran-Robert-J-Dempsey-as-Interim-CEO-Following-Positive-Phase-2-Results-and-FDA-Alignment-on-Pivotal-Program.html

08 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/08/3163285/0/en/Ashvattha-Therapeutics-to-Present-Phase-2-DME-and-nAMD-Data-at-Innovate-Retina.html

26 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/26/3139187/0/en/Ashvattha-Therapeutics-to-Present-Late-Breaking-Phase-2-DME-and-nAMD-Data-at-25th-EURETINA-Congress.html

30 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/30/3107454/0/en/Ashvattha-Therapeutics-Presents-Positive-Interim-Phase-2-Results-for-Subcutaneous-Migaldendranib-Treatment-for-DME-and-Wet-AMD-at-2025-MaculArt-Meeting.html

23 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/23/3103349/0/en/Ashvattha-Therapeutics-Reports-the-Ability-to-Tune-Nanomedicines-to-Image-Neuroinflammation-in-Multiple-Sclerosis-Patients-and-Tumor-Associated-Macrophages-in-Cancer-at-SNMMI-Annua.html
ABOUT THIS PAGE
Ashvattha Therapeutics is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of F-OP-801 bulk with DMF offered by Ashvattha Therapeutics
Find a price of 18F-OP-801 bulk with DMF offered by Ashvattha Therapeutics